Back
  • Poster Presentation
  • P-SMNP-001

A new biosynthetic route enlarges the terpene portfolio of bacteria

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
Poster Exhibition

Poster

A new biosynthetic route enlarges the terpene portfolio of bacteria

Topic

  • Secondary metabolites and natural products

Authors

Birgit Piechulla (Rostock / DE), Nancy Schmidt (Rostock / DE), Katja Baer (Rostock / DE), Stephan von Reuss (Neuchatel / CH)

Abstract

Introduction: The class of terpenoids remain one of the largest groups of natural products (ca. 80,000 compounds, 1), which are structurally and functionally diverse (e.g. rubber, cholesterin, carotenoides, gibberellin, caryophyllene, geraniol, limonene), and many have pharmacological activities (e.g. artemisinin, taxol). Their biosyntheses are based on the reactions of C5 building blocks through head-to-tail, head-to-head, head-to-middle to generate terpene backbones (prenylpyrophosphates) of C10, C15, C20 etc. (2, 3). These backbones can be further rearranged and cyclized by terpene synthases. Furthermore, the regular length compounds can be modified by tailoring enzymes, e.g. methylations, hydroxylation, oxygenation or degradation to reveal irregulare terpenes.

Recently we could show that in bacteria an alternative biosynthetic pathway produces irregulare, non-canonical terpenes via C16 and C17 prenylpyrophosphates (terpene backbones). Two enzyme classes with unusual catalytic capacities and substrate specificities are required to synthesize these non-canonical homo- and bishomo-sesquiterpenes, e.g., sodorifen, chlororaphen (4, 5). The first enzyme is a SAM-dependent bifunctional FPP-methyltransferase with cyclization activity, the second enzyme is a species-specific terpene synthase that accepts (only) cyclic prenylpyrophosphates as substrates.

Results and Discussion: Here we present the state of the art of this new biosynthetic route and demonstrate its presence in α-, β- and γ-proteobacteria and a Streptomyces species. Alltogether this biosynthetic pathway contributes to the diversity of the microbial natural terpenomes and we propose that the 136-year-old isoprene dogma should be modified. Furthermore, this non-canonical terpene biosynthesis inspires potential applications (6).

References

D.W. Christianson (2017). Chem Rev 117, 11570–11648.O. Wallach (1887). Justus Liebig's Annalen der Chemie 238: 78–89.L. Ruzicka (1953). Experientia 9: 357–367.S. von Reuss et al. (2018). J Am Chem Soc 140, 11855–11862N. Magnus et al. (2023). Ang Chem Int Ed Engl e202303692R. Chen et al. (2024). Trends in Biotech. 2447
    • v1.19.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy